The value of glycosylated hemoglobin (HbA1c) as a predictive risk factor in the diagnosis of diabetes mellitus (DM) in the elderly

Archives of Gerontology and Geriatrics

Volumn 50, Issue 1, 2010, Pages 60-64

  Motta, M ^a   Bennati, E ^a   Cardillo, E ^a   Ferlito, L ^a   Malaguarnera, M ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Glycosylated hemoglobin (HbA1c); Impaired fasting glucose (IFG); Normal fasting glucose (NFG); Predictive diagnosis of diabetes mellitus

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

AGED; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SENSITIVITY AND SPECIFICITY; VALIDITY;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; AGING; BLOOD GLUCOSE; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; GERIATRIC ASSESSMENT; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; PREDICTIVE VALUE OF TESTS; PROBABILITY; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION;

EID: 70449686659     PISSN: 01674943     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archger.2009.01.012     Document Type: Article

References (39)

1. ADA (American Diabetes Association). Clinical practice recommendations: standards of medical care for patients with diabetes mellitus. Diabetes Care 26 (2003) S33-S50
2. ADA (American Diabetes Association). Standards of medical care in diabetes mellitus. Diabetes Care 30 (Suppl. 1) (2007) S4-S41
3. Balkau B., Forhan A., Simon D., and Eschwège E. HbA1c as a diagnostic tool for diabetes. Internat. Congr. Series 1253 (2003) 19-26
4. Bennett C.M., Guo M., and Dharmage S.C. HbA1c as a screening tool for detection of Type 2 diabetes: a systematic review. Diabet. Med. 24 (2007) 333-343
5. Bodhini D., Radha V., Dhar M., Narayani N., and Mohan V. The rs12255372-(G/T) and rs7903146(C/T) polymorphisms of the TCF7L2 gene are associated with type 2 diabetes mellitus in Asian Indians. Metabolism 56 (2007) 1174-1178
6. Buell C., Kermah D., and Davidson M.B. Utility of A1C for diabetes screening in the 1999-2004 NHANES III population. Diabetes Care 30 (2007) 2233-2235
7. Davidson M.B., Peters A.L., and Schriger D.L. An alternative approach to the diagnosis of diabetes with a review of the literature. Diabetes Care 18 (1995) 1065-1071
8. Davidson M.B., Schriger D.L., Peters A.L., and Lorber B. Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria. J. Am. Med. Assoc. 281 (1999) 1203-1210
9. Droumaguet C., Balkau B., Simon D., Caces E., Tichet J., Charles M.A., and Eschwege E. the DESIR Study Group. Use of HbA1c in predicting progression to diabetes in French men and women: data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care 29 (2006) 1619-1625
10. Edelman D., Olsen M.K., Dudley T.K., Harris A.C., and Oddone E.Z. Utility of hemoglobin A1c in predicting diabetes risk. J. Gen. Intern. Med. 19 (2004) 1175-1180
11. Gao, L., Matthews, F.E., Sargeant, L.A., Brayne, C., MRC Cognitive Function and Ageing Study (corporate author), 2008. An investigation of the population impact of variation in HbA1c levels in older people in England and Wales: from a population based multi-centre longitudinal study. BMC Public Health 8, 54 (epub. February 11, 2008. doi:10.1186/1471-2458-8-54).
12. Goldstein D.E. Isn't it time to retire the oral glucose tolerance test for diabetes screening and diagnosis?. Diabetes Care 21 (1998) 1215-1216
13. Grant S.F., Thorleifsson G., Reynisdottir I., Benediktsson R., Manolescu A., Sainz J., Helgason A., Stefansson H., Emilsson V., Helgadottir A., Styr-karsdottir U., Magnusson K.P., Walters G.B., Palsdottir E., Jonsdottir T., Gudmundsdottir T., Gylfason A., Saemundsdottir J., Wilensky R.L., Reilly M.P., Rader D.J., Bagger Y., Christiansen C., Gudnason V., Sigurdsson G., Thorsteinsdottir U., Gulcher J.R., Kong A., and Stefansson K. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat. Genet. 38 (2006) 320-323
14. Harris M.I., and Eastman R.C. Early detection of undiagnosed non-insulin-dependent diabetes mellitus. J. Am. Med. Assoc. 276 (1996) 1261-1262
15. ILSA (Italian Longitudinal Study on Aging) Working Group. Prevalence of chronic diseases in older Italians: comparing self reported and clinical diagnosis. Int. J. Epidemiol. 26 (1997) 995-1002
16. Inoue K., Matsumoto M., and Kobayashi Y. The combination of fasting plasma glucose and glycosylated hemoglobin predicts type 2 diabetes in Japanese workers. Diabetes Res. Clin. Pract. 77 (2007) 451-458
17. Jesudason D.R., Dunstan K., Leong D., and Wittert G.A. Macrovascular risk and diagnostic criteria for type 2 diabetes: implications for the use of FPG and HbA1c for cost-effective screening. Diabetes Care 26 (2003) 485-490
18. Jorde R., and Hagen T. Screening for diabetes using HbA1c in elderly subjects. Acta Diabetol. 43 (2006) 52-56
19. Kilpatrick E.S., Maylor P.W., and Keevil B.G. Biological variation of glycated hemoglobin. Implications for diabetes screening and monitoring. Diabetes Care 21 (1998) 261-264
20. Little R.R., England J.D., Wiedmeyer H.M., McKenzie E.M., Pettitt D.J., Knowler W.C., and Goldstein D.E. Relationship of glycosylated hemoglobin to oral glucose tolerance. Implications for diabetes screening. Diabetes 37 (1988) 60-64
21. Maggi S., Zucchetto M., Grigoletto F., Baldereschi M., Candelise L., Scarpini E., Scarlato G., and Amaducci L. The Italian Longitudinal Study on Aging (ILSA): design and methods. Aging (Milano) 6 (1994) 464-473
22. McCance D.R., Hanson R.L., Charles M.A., Jacobsson L.T., Pettitt D.J., Bennett P.H., and Knowler W.C. Which test for diagnosing diabetes?. Diabetes Care 18 (1995) 1042-1044
23. Motta L., and Carnazzo G. Diabetes in the elderly. Lecture at the 95th Congress of the Italian Society of Internal Medicine. Ed. Luigi Pozzi, Rome (1994) pp. 7-8 (in Italian)
24. Motta M., Bennati E., Ferlito L., and Malaguarnera M. Diabetes mellitus in the elderly: diagnostic features. Arch. Gerontol. Geriatr. 42 (2006) 101-106
25. Motta M., Bennati E., Cardillo E., and Malaguarnera M. Pathogenesis of the senile diabetes. Indian J. Med. Res. 128 (2008) 225-227
26. National Diabetes Data Group (NDDG), 1979. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28, 1039-1057.
27. Norberg M., Eriksson J.W., Lindahl B., Andersson C., Rolandsson O., Stenlund H., and Weinehall L. A combination of HbA1c, fasting glucose and BMI is effective in screening for individuals at risk of future type2 diabetes: OGTT is not needed. J. Int. Med. 260 (2006) 263-271
28. Pendleton N., Clague J.E., Cobain M., Thethi K., Jones M., Horan M.A., MecInnes L., and Rabbitt P.M. Relationship between self-reported prevalence of diabetes mellitus using the Cornell Medical Index (CMI) and prevalence determined by glycosylated hemoglobin (HbA1c) in an elderly community-dewelling population. Arch. Gerontol. Geriatr. 41 (2005) 289-296
29. Peters A.L., Davidson M.B., Schriger D.L., and Hasselblad V. A clinical approach for the diagnosis of diabetes mellitus: an analysis using glycosylated hemoglobin levels. Meta-analysis Research Group on the Diagnosis of Diabetes Using Glycated Hemoglobin Levels. J. Am. Med. Assoc. 276 (1996) 1246-1252
30. 1c in screening for diabetes. Diabetes Care 21 (1998) 1577-1578
31. Rowley K.G., Daniel M., and O'Dea K. Screening for diabetes in Indigenous populations using glycated haemoglobin: sensitivity, specificity, post-test likelihood and risk of disease. Diabet. Med. 22 (2005) 833-839
32. Sämann A., Kaiser J., Hunger-Dathe W., Schiel R., and Müller U.A. Population-based measurement of quality of diabetes care using HbA1c values in the state of Thuringia/Germany. Exp. Clin. Endocrinol. Diabetes 112 (2004) 531-537
33. Smith Jr. S.C., Allen J., Blair S.N., Bonow R.O., Brass L.M., Fonarow G.C., Grundy S.M., Hiratzka L., Jones D., Krumholz H.M., Mosca L., Pasternak R.C., Pearson T., Pfeffer M.A., and Taubert K.A. AHA/ACC; National Heart, Lung, and Blood Institute, AHA/ACC Guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006-update, endorsed by the National Heart, Lung, and Blood Institute. Circulation 113 (2006) 2363-2372
34. Takahashi K., Uchiyama H., Yanagisawa S., and Kamae I. The logistic regression and ROC analysis of group-based screening for predicting diabetes incidence in four years. Kobe J. Med. Sci. 52 (2006) 171-180
35. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, 1997. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20, 1183-1197.
36. UKPDS (United Kingdom Prospective Diabetes Study). Intensive blood control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with Type 2 diabetes (UKPDS 33). Lancet 352 (1998) 1012-1015
37. WHO (World Health Organization) Consultation, 1999. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Part 1. Diagnosis and Classification of Diabetes Mellitus. WHO, Department of No Communicable Disease Surveillance, Genf.
38. Zeggini E., and McCarthy M.I. TCF7L2: the biggest story in diabetes genetics since HLA?. Diabetologia 50 (2007) 1-4
39. Zeggini E., Scott L.J., Saxena R., Voight B.F., Marchini J.L., Hu T., De Bakker P.I., Becasis G.R., Almgren P., Andersen G., Ardlie K., Boström K.B., Bergman R.N., Bonnycastle L.L., Borch-Johnsen K., Burtt N.P., Chen H., Chines P.S., Daly M.J., Deodhar P., Ding C.J., Doney A.S., Duren W.L., Elliott K.S., Erdos M.R., Frayling T.M., Freathy R.M., Gianniny L., Grallert H., Grarup N., Groves C.J., Guiducci C., Hansen T., Herder C., Hitman G.A., Hughes T.E., Isomaa B., Jackson A.U., Jørgensen T., Kong A., Kubalanza K., Kuruvilla F.G., Kuusisto J., Langenberg C., Lango H., Lauritzen T., Li Y., Lindgren C.M., Lyssenko V., Marvelle A.F., Meisinger C., Midthjell K., Mohlke K.L., Morken M.A., Morris A.D., Narisu N., Nilsson P., Owen K.R., Palmer C.N., Payne F., Perry J.R., Pettersen E., Platou C., Prokopenko I., Qi L., Qin L., Rayner N.W., Rees M., Roix J.J., Sandbæk A., Shields B., Sjögren M., Steinthorsdottir V., Stringham H.M., Swift A.J., Thorleifsson G., Thorsteinsdottir U., Timpson N.J., Tuomi T., Tuomilehto J., Walker M., Watanabe R.M., Weedon M.N., Willer C.J., Wellcome Trust Case Control Consortium, Illig T., Hveem K., Hu F.B., Laakso M., Stefansson K., Pedersen O., Wareham N.J., Barroso I., Hattersley A.T., Collins F.S., Groop L., McCarthy M.I., Boehnke M., and Altshuler D. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat. Genet. 40 (2008) 638-645 10.1038/ng.120